[HTML][HTML] Role of distinct natural killer cell subsets in anticancer response

H Stabile, C Fionda, A Gismondi, A Santoni - Frontiers in immunology, 2017 - frontiersin.org
Natural killer (NK) cells, the prototypic member of innate lymphoid cells, are important
effectors of anticancer immune response. These cells can survey and control tumor initiation …

[HTML][HTML] Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging

DP Muñoz, SM Yannone, A Daemen, Y Sun… - JCI insight, 2019 - ncbi.nlm.nih.gov
Cellular senescence is a tumor-suppressive mechanism that can paradoxically contribute to
aging pathologies. Despite evidence of immune clearance in mouse models, it is not known …

[HTML][HTML] Tissue factor as a new target for CAR-NK cell immunotherapy of triple-negative breast cancer

Z Hu - Scientific reports, 2020 - nature.com
Triple-negative breast cancer (TNBC), representing~ 15% of globally diagnosed breast
cancer, is typically an incurable malignancy due to the lack of targetable surface targets for …

[HTML][HTML] Natural killer cells in the human lung tumor microenvironment display immune inhibitory functions

J Russick, PE Joubert, M Gillard-Bocquet… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Background Natural killer (NK) cells play a crucial role in tumor immunosurveillance through
their cytotoxic effector functions and their capacity to interact with other immune cells to build …

NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma

C Sun, H Sun, C Zhang, Z Tian - Cellular & molecular immunology, 2015 - nature.com
Hepatocellular carcinoma (HCC) is currently the third leading cause of cancer mortality and
a common poor-prognosis malignancy due to postoperative recurrence and metastasis …

Triple negative breast cancer–prognostic role of immune-related factors: a systematic review

ES Stovgaard, D Nielsen, E Hogdall, E Balslev - Acta Oncologica, 2018 - Taylor & Francis
Purpose: Treatment of breast cancer has been increasingly successful in recent years with
the advent of HER2-receptor targeted treatment and endocrine treatment. However, the …

[HTML][HTML] A phase 1 study of lirilumab (antibody against killer immunoglobulin-like receptor antibody KIR2D; IPH2102) in patients with solid tumors and hematologic …

N Vey, L Karlin, S Sadot-Lebouvier, F Broussais… - Oncotarget, 2018 - ncbi.nlm.nih.gov
A phase 1 study of lirilumab (antibody against killer immunoglobulin-like receptor antibody
KIR2D; IPH2102) in patients with solid tumors and hematologic malignancies - PMC Back to …

[HTML][HTML] Killers 2.0: NK cell therapies at the forefront of cancer control

JJ Hodgins, ST Khan, MM Park… - The Journal of …, 2019 - Am Soc Clin Investig
Natural killer (NK) cells are innate cytotoxic lymphocytes involved in the surveillance and
elimination of cancer. As we have learned more and more about the mechanisms NK cells …

Exhausted NK cells and cytokine storms in COVID-19: Whether NK cell therapy could be a therapeutic choice

M Ghasemzadeh, A Ghasemzadeh, E Hosseini - Human immunology, 2022 - Elsevier
The global outbreak of coronavirus-2019 (COVID-19) still claims more lives daily around the
world due to the lack of a definitive treatment and the rapid tendency of virus to mutate …

[HTML][HTML] Natural killer cell interactions with myeloid derived suppressor cells in the tumor microenvironment and implications for cancer immunotherapy

C Zalfa, S Paust - Frontiers in Immunology, 2021 - frontiersin.org
The tumor microenvironment (TME) is a complex and heterogeneous environment
composed of cancer cells, tumor stroma, a mixture of tissue-resident and infiltrating immune …